TOMI Environmental Solutions, Inc. TOMZ

Healthcare SIC 2860 - Industrial Organic Chemicals Nasdaq

TOMI Environmental Solutions, Inc. ("TOMI," "we," "our," or the "Company") is a global provider of disinfection and decontamination solutions, offering environmentally friendly products and services for indoor air and surface treatment. Our flagship product line, SteraMist uses our patented Binary Ionization Technology ("BIT") to deliver a low-concentration (7.8%) hydrogen peroxide-based fog or mist that effectively treats all indoor environments and surface areas.

Developed under a grant from the United States Defense Advanced Research Projects Agency ("DARPA"), SteraMist generates ionized Hydrogen Peroxide ("iHP") through a high-voltage atmospheric cold plasma arc, converting hydrogen peroxide solution into submicron hydroxyl radical particles. This process achieves a 6-log (99.9999%) or greater kill rate against a broad spectrum of pathogens, leaving only oxygen and humidity as by-products. We maintain U.S. Environmental Protection Agency ("EPA") registration for our BIT solution, along with applicable regulatory approvals in all 50 states, Washington D.C., Canada, and approximately 40 other countries.

Last close 1.70 2026-09-04
Market cap $13.8M 2026-06-30 share count
52-week range 1.39 - 3.42

Valuation FY2025 figures against the last close

P/S2.5x
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS-0.19

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.6M$7.7M$7.4M$8.3M$7.8M$25.0M$6.3M$5.6M$5.0M$6.3M
Cost of revenue $2.6M$4.2M$3.1M$3.3M$3.2M$10.0M$2.4M$2.5M$1.9M$2.6M
Gross profit $3.1M$3.6M$4.3M$5.1M$4.6M$15.0M$3.9M$3.1M$3.1M$3.7M
R&D $289.9K$290.7K$491.8K$352.2K$572.7K$455.0K$340.6K$916.0K$454.1K$184.3K
SG&A $4.5M$5.1M$4.6M
Total operating expenses $6.9M$7.7M$7.6M$7.9M$9.5M$10.5M$6.0M$6.2M$6.5M$7.1M
Operating income -$3.9M-$4.1M-$3.3M-$2.9M-$4.9M$4.5M-$2.1M-$3.1M-$3.4M-$3.4M
Interest expense $63.3K$0$1.0K$43.5K$200.0K$221.9K$191.3K$0
Pre-tax income -$3.7M-$4.5M-$3.4M-$2.9M-$4.5M$4.5M-$2.3M-$3.2M-$3.6M-$3.2M
Income tax $0$0$0$0$74.1K$77.0K$0$0$0$0
Net income -$3.7M-$4.5M-$3.4M-$2.9M-$4.4M$4.4M-$2.3M-$3.2M-$3.6M-$3.2M
EPS, basic -0.19-0.22-0.17-0.15-0.250.27-0.15
EPS, diluted -0.19-0.22-0.17-0.15-0.250.23-0.15-0.03-0.03-0.03
Shares, diluted (wtd. avg.) $20.1M$20.0M$19.8M$19.7M$17.5M$18.8M$15.6M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $87.8K$88.0K$2.3M$3.9M$5.3M$5.2M$897.2K$2.0M$4.6M$948.3K
Receivables $689.2K$1.9M$2.4M$2.8M$2.0M$3.7M$1.5M$2.1M$1.8M$1.5M
Inventory $2.9M$3.6M$4.6M$4.5M$4.7M$3.8M$2.3M$2.7M$3.5M$4.0M
Total current assets $4.2M$6.5M$10.0M$12.1M$12.9M$13.7M$5.0M$7.2M$10.2M$6.8M
Property, plant and equipment $614.3K$875.4K$1.0M$1.3M$1.5M$1.3M$1.4M$1.6M$712.8K$611.8K
Other intangibles $1.4M$1.3M$1.1M$1.0M$956.3K$722.9K$939.0K$1.2M$1.5M$1.9M
Total assets $7.0M$9.7M$13.4M$15.5M$16.3M$16.8M$8.2M$10.1M$12.4M$9.3M
Accounts payable $1.5M$1.9M$1.3M$1.8M$1.1M$1.5M$713.2K$1.1M$751.7K$735.9K
Total current liabilities $3.2M$2.7M$2.1M$3.3M$1.8M$2.2M$6.3M$1.7M$1.1M$1.1M
Long-term debt $3.1M$5.0M$5.0M$5.9M
Total liabilities $6.4M$5.6M$5.0M$4.1M$2.7M$3.6M$7.3M$7.1M$7.0M$1.1M
Retained earnings -$58.1M-$54.3M-$49.8M-$46.4M-$43.5M-$39.1M-$43.5M-$41.2M-$38.0M-$34.3M
Total equity $588.5K$4.1M$8.4M$11.4M$13.6M$13.2M$889.5K$3.0M$5.4M$8.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$1.2M-$1.4M-$3.6M-$1.2M-$3.8M$4.6M-$814.5K-$1.8M-$2.4M-$4.5M
Depreciation and amortisation $241.5K$270.2K$345.6K$314.7K$299.7K$342.5K$345.7K$265.2K$237.6K$216.9K
Stock-based compensation $147.0K$144.3K$163.3K$653.8K$3.1M$114.2K$77.2K$649.3K$614.7K
Capital expenditure $5.2K$107.9K$98.1K$200.9K$289.3K$145.6K$628.1K$14.8K$474.9K
Investing cash flow -$135.6K-$261.5K-$216.7K-$241.4K-$639.4K-$400.7K-$293.3K-$628.1K-$14.8K-$462.9K
Financing cash flow $755.1K$27.5K$2.3M$25.0K$4.6M$124.2K$0-$150.0K$6.0M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001654954-26-003091.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $22.03B -5.2%
LYB LyondellBasell Industries N.V. $20.52B -9.7%
WLK WESTLAKE CORP $9.56B -8.0%
NEU NEWMARKET CORP $8.14B 19.9x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.74B 42.7x 3.5%
REX REX AMERICAN RESOURCES Corp $1.38B 16.6x 1.2%
GPRE Green Plains Inc. $1.08B 16.0%
WLKP Westlake Chemical Partners LP $771.2M 2.7%